How should I manage severe hyperglycemia with blood glucose in the 500 mg/dL range despite treatment with empagliflozin (Jardiance), metformin/sitagliptin (Janumet), insulin glargine (Lantus) 20 units daily, and regular insulin (Novolin) 10 units with each large meal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Severe Hyperglycemia (Blood Glucose 500 mg/dL) Despite Current Multi-Drug Regimen

You need to immediately discontinue Jardiance (empagliflozin) and significantly intensify your insulin therapy using a basal-bolus regimen, as severe hyperglycemia >300 mg/dL requires a more complex insulin regimen rather than oral agents. 1

Immediate Actions Required

Discontinue SGLT2 Inhibitor

  • Stop Jardiance immediately due to the risk of diabetic ketoacidosis (DKA), which can occur even with blood glucose levels below 250 mg/dL 2
  • SGLT2 inhibitors are contraindicated in severe hyperglycemia and increase ketoacidosis risk, particularly dangerous when glucose control is this poor 2, 3

Intensify Insulin Therapy

For severe hyperglycemia >300 mg/dL (16.6 mmol/L), a basal-bolus insulin regimen is indicated 1:

  • Increase basal insulin (Lantus): Your current 20 units daily is inadequate. Calculate total daily dose (TDD) at 0.3-0.5 U/kg body weight, giving half as basal insulin 1
  • Intensify mealtime insulin: Your current Novolin 10 units twice daily is insufficient. Switch to a proper bolus regimen with rapid-acting insulin before each meal (not just large meals), giving the other half of TDD divided among three meals 1
  • Add correction doses: Use rapid-acting insulin for correction before meals or every 6 hours to bring down the 500 mg/dL readings 1

Medication Adjustments

Continue Janumet (Sitagliptin/Metformin)

  • Keep metformin as it reduces insulin requirements, decreases weight gain, and lowers hypoglycemia risk when combined with insulin 4, 5
  • Keep sitagliptin (DPP-4 inhibitor) as it can be safely continued with intensive insulin therapy and may reduce insulin needs 6, 7
  • Do not abruptly discontinue these oral agents to avoid rebound hyperglycemia 5

Insulin Dosing Algorithm

For blood glucose in the 500s with current insulin resistance 1:

  1. Calculate new TDD: If you weigh 80 kg, start with 0.4 U/kg = 32 units TDD minimum (likely need 0.5-0.6 U/kg given severity)
  2. Split dosing: 50% basal (Lantus at bedtime), 50% bolus (divided among three meals)
  3. Example for 80 kg patient: Lantus 20-24 units at bedtime + rapid-acting insulin 6-8 units before each meal
  4. Titrate aggressively: Increase basal by 2-4 units every 2-3 days until fasting glucose <130 mg/dL 1

Critical Monitoring

Check for Ketoacidosis

  • Measure urine or blood ketones immediately given the severe hyperglycemia and SGLT2 inhibitor use 2
  • If ketones are present, seek emergency care as this may require IV insulin infusion 1

Blood Glucose Monitoring

  • Check fasting glucose to titrate basal insulin 4
  • Check pre-meal and 2-hour post-meal glucose to titrate bolus insulin 4
  • Monitor at least 4 times daily until glucose consistently <200 mg/dL 1

Common Pitfalls to Avoid

Do not continue SGLT2 inhibitors with severe hyperglycemia - they are ineffective when glucose is this high and increase DKA risk 1, 2

Do not use premixed insulin - you need the flexibility of separate basal and bolus adjustments with this degree of hyperglycemia 1

Do not stop metformin when intensifying insulin - this combination reduces weight gain and hypoglycemia 4, 5

Do not delay insulin intensification - therapeutic inertia with severe hyperglycemia leads to complications 4

When to Seek Immediate Care

Seek emergency evaluation if you experience 2:

  • Nausea, vomiting, or abdominal pain
  • Unusual fatigue or trouble breathing
  • Positive ketones in urine
  • Inability to keep down fluids

Follow-Up Plan

  • Reassess in 3-5 days after insulin intensification to adjust doses based on glucose patterns 1
  • Target fasting glucose <130 mg/dL and pre-meal glucose <130 mg/dL initially 1
  • Once stable, consider re-introducing empagliflozin only if HbA1c remains >7.5% despite optimized insulin, but never with glucose >300 mg/dL 4, 8

Related Questions

A 67-year-old male with hemoglobin A1c 8.3% on metformin 2000 mg daily developed a rash after starting empagliflozin (Jardiance) 10 mg and stopped it; what alternative glucose‑lowering therapy should be added?
What is the ideal self‑monitoring of blood glucose (SMBG) schedule to assess adequacy of treatment with pre‑meal NovoMix 30 (insulin aspart protamine/insulin aspart) pen insulin?
For a 70‑year‑old patient with diabetes using a Humalog (insulin lispro) U‑100 pen, injecting 6–14 units subcutaneously before each of three daily meals, what sliding‑scale correction insulin dosing should be used?
What should I do for an 81‑year‑old woman with dementia, hyperlipidemia, and type 2 diabetes whose hemoglobin A1c has risen to 7.5% while she is taking insulin glargine (Lantus) 10 U daily, insulin lispro (Humalog) 6 U with meals, and empagliflozin (Jardiance) 10 mg daily?
What monitoring and follow‑up plan should be used when initiating metformin, an SGLT2 inhibitor, a GLP‑1 receptor agonist, and basal insulin in a patient with type 2 diabetes?
What is the appropriate dose of Epogen (epoetin alfa) for a patient with a hemoglobin of 8.9 g/dL?
What is the minimum platelet count required to safely perform an epidural steroid injection?
What is the recommended corticosteroid regimen for an adult with moderate to severe Pneumocystis jirovecii pneumonia?
What laboratory findings are characteristic of disseminated intravascular coagulation?
What is the recommended management for post‑perfusion lung syndrome?
Can antidepressant and antipsychotic medications cause new onset overactive bladder symptoms, and what is the recommended management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.